These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28656663)

  • 1. In Situ Capture of Bacterial Toxins for Antivirulence Vaccination.
    Wei X; Gao J; Wang F; Ying M; Angsantikul P; Kroll AV; Zhou J; Gao W; Lu W; Fang RH; Zhang L
    Adv Mater; 2017 Sep; 29(33):. PubMed ID: 28656663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiantigenic Nanotoxoids for Antivirulence Vaccination against Antibiotic-Resistant Gram-Negative Bacteria.
    Wei X; Ran D; Campeau A; Xiao C; Zhou J; Dehaini D; Jiang Y; Kroll AV; Zhang Q; Gao W; Gonzalez DJ; Fang RH; Zhang L
    Nano Lett; 2019 Jul; 19(7):4760-4769. PubMed ID: 31184899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.
    Angsantikul P; Fang RH; Zhang L
    Bioconjug Chem; 2018 Mar; 29(3):604-612. PubMed ID: 29241006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-detained toxins for safe and effective vaccination.
    Hu CM; Fang RH; Luk BT; Zhang L
    Nat Nanotechnol; 2013 Dec; 8(12):933-8. PubMed ID: 24292514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulatory DNA Hydrogel Enhances Protective Efficacy of Nanotoxoids against Bacterial Infection.
    Guo Z; Zhou J; Yu Y; Krishnan N; Noh I; Zhu AT; Borum RM; Gao W; Fang RH; Zhang L
    Adv Mater; 2023 Aug; 35(31):e2211717. PubMed ID: 37097076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic Neutrophil Nanotoxoids Elicit Potent Immunity against
    Zhou J; Ventura CJ; Yu Y; Gao W; Fang RH; Zhang L
    Nano Lett; 2022 Sep; 22(17):7057-7065. PubMed ID: 35998891
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanotoxoid Vaccines.
    Hu CM; Zhang L
    Nano Today; 2014 Aug; 9(4):401-404. PubMed ID: 25285152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges.
    Chen Y; Chen M; Zhang Y; Lee JH; Escajadillo T; Gong H; Fang RH; Gao W; Nizet V; Zhang L
    Adv Healthc Mater; 2018 Jul; 7(13):e1701366. PubMed ID: 29436150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant
    Wang F; Fang RH; Luk BT; Hu CJ; Thamphiwatana S; Dehaini D; Angsantikul P; Kroll AV; Pang Z; Gao W; Lu W; Zhang L
    Adv Funct Mater; 2016 Mar; 26(10):1628-1635. PubMed ID: 27325913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
    Ghaffari Marandi BH; Zolfaghari MR; Kazemi R; Motamedi MJ; Amani J
    Microb Pathog; 2019 Sep; 134():103600. PubMed ID: 31202906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotoxoid vaccination protects against opportunistic bacterial infections arising from immunodeficiency.
    Zhou J; Krishnan N; Guo Z; Ventura CJ; Holay M; Zhang Q; Wei X; Gao W; Fang RH; Zhang L
    Sci Adv; 2022 Sep; 8(36):eabq5492. PubMed ID: 36083909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection.
    Zhang Y; Zhang J; Chen W; Angsantikul P; Spiekermann KA; Fang RH; Gao W; Zhang L
    J Control Release; 2017 Oct; 263():185-191. PubMed ID: 28087406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic Nanotechnology toward Personalized Vaccines.
    Zhou J; Kroll AV; Holay M; Fang RH; Zhang L
    Adv Mater; 2020 Apr; 32(13):e1901255. PubMed ID: 31206841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteria
    Jiang L; Zhu Y; Luan P; Xu J; Ru G; Fu JG; Sang N; Xiong Y; He Y; Lin GQ; Wang J; Zhang J; Li R
    ACS Nano; 2021 Mar; 15(3):4173-4185. PubMed ID: 33606516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic Nanosponges Suppress In Vivo Lethality Induced by the Whole Secreted Proteins of Pathogenic Bacteria.
    Chen Y; Zhang Y; Chen M; Zhuang J; Fang RH; Gao W; Zhang L
    Small; 2019 Feb; 15(6):e1804994. PubMed ID: 30637970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform.
    Angsantikul P; Thamphiwatana S; Gao W; Zhang L
    Vaccines (Basel); 2015 Oct; 3(4):814-28. PubMed ID: 26457720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Micromotor Enables Active Delivery of Antigens for Oral Vaccination.
    Wei X; Beltrán-Gastélum M; Karshalev E; Esteban-Fernández de Ávila B; Zhou J; Ran D; Angsantikul P; Fang RH; Wang J; Zhang L
    Nano Lett; 2019 Mar; 19(3):1914-1921. PubMed ID: 30724085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections.
    Coburn PS; Miller FC; LaGrow AL; Land C; Mursalin H; Livingston E; Amayem O; Chen Y; Gao W; Zhang L; Callegan MC
    mSphere; 2019 May; 4(3):. PubMed ID: 31092603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.